Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 3, 2020 - Prasco launched an authorized brand alternative of Symbicort (budesonide/formoterol) inhalation.
Download PDF
Return to publications
